NeueHealth Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-50.24	-99.72	-1,266	-1,360	-1,185	-248.44
Depreciation & Amortization	14.22	15.65	24.17	50.58	35.48	8.29
Stock-Based Compensation	40.3	70.21	83.69	109.71	68.42	5.45
Other Adjustments	-32.78	-61.49	574.76	274.07	-85.63	2.67
Change in Receivables	90.31	18.8	-24.45	-70.39	-32.94	24.63
Changes in Accounts Payable	-2.04	-3.94	-149.33	2.7	192.61	-3.96
Changes in Accrued Expenses	-65.83	-69.57	-2,288	1,292	1,218	179.57
Changes in Unearned Revenue	0.09	0.08	-10.61	-42.76	14.9	18.62
Changes in Other Operating Activities	-63.98	6.76	329.39	-21.83	-143.46	-44.06
Operating Cash Flow	-69.94	-123.22	-2,727	234.47	82.06	-57.24
Operating Cash Flow Growth	-	-	-	185.73%	-	-
Capital Expenditures	-4.11	-2.33	-2.9	-27.45	-30.41	-6.47
Purchases of Investments	-13.64	-14.96	-837.07	-1,457	-1,018	-916.82
Proceeds from Sale of Investments	8.88	7.07	1,960	1,055	926.9	463.89
Payments for Business Acquisitions	-	-	-	-0.31	-431.79	-230.33
Proceeds from Business Divestments	61.14	197.12	-0.68	-	-	-
Investing Cash Flow	52.26	186.89	1,120	-429.72	-552.89	-689.74
Short-Term Debt Issued	2	2	-	303.95	355	-
Short-Term Debt Repaid	-1	-273.64	-	-155	-200	-
Net Short-Term Debt Issued (Repaid)	1	-271.64	-	148.95	155	-
Long-Term Debt Issued	67.39	119.8	66.4	-	-	-
Net Long-Term Debt Issued (Repaid)	67.39	119.8	66.4	-	-	-
Issuance of Common Stock	-	-	-	1.32	898.72	1.24
Net Common Stock Issued (Repurchased)	-	-	-	1.32	898.72	1.24
Issuance of Preferred Stock	-	-	-	920.42	-	711.2
Net Preferred Stock Issued (Repurchased)	-	-	-	920.42	-	711.2
Other Financing Activities	-99.24	-101.72	-16.49	-4.31	-10.08	-
Financing Cash Flow	-30.85	-253.55	49.91	1,066	1,044	712.44
Net Cash Flow	-48.53	-189.88	-1,557	871.11	572.81	-34.54
Beginning Cash & Cash Equivalents	261.46	375.28	1,932	1,061	488.37	522.91
Ending Cash & Cash Equivalents	212.93	185.41	375.28	1,932	1,061	488.37
Free Cash Flow	-74.05	-125.55	-2,729	207.02	51.65	-63.71
Free Cash Flow Growth	-	-	-	300.85%	-	-
FCF Margin	-8.34%	-13.42%	-235.15%	25.67%	3.41%	-12.37%
Free Cash Flow Per Share	-8.70	-15.26	-343.15	26.31	10.53	-37.42
Levered Free Cash Flow	-188.05	-391.51	-3,232	-92.77	256.79	-96.46
Unlevered Free Cash Flow	-155.11	-164.64	-2,673	937.18	969.09	-9.24

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q